This drug has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous.
Bearing expiration dates into 2027.
HONOLULU, HI—Minimal systemic distribution of topical diclofenac sodium gel resulted in a lower incidence of major or moderate drug-drug interactions associated with oral diclofenac and reduced the ...
Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist ...
September 28, 2011 (San Diego, California) — A topical formulation of the nonsteroidal anti-inflammatory drug (NSAID) diclofenac sodium 1% gel (Voltaren Gel, Endo Pharmaceuticals) shows safety and ...
DUBLIN, Sept. 8, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has launched the store brand equivalent of over-the-counter ("OTC") Voltaren® Arthritis Pain ...
FDA-Approved Product Is the First Prescription NSAID (Nonsteroidal Anti-Inflammatory Drug) That Patients Can Apply Directly to the Skin at the Site of Pain Associated With Osteoarthritis; Voltaren Gel ...
Novartis Corporation Voltaren Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis PARSIPPANY, N.J., Oct. 22 -- Voltaren(R) ...
First US approval for a prescription NSAID (non-steroidal anti-inflammatory drug) treatment that can be applied directly to site of osteoarthritis pain Voltaren Gel is the only prescription topical ...
WARREN, N.J., Feb. 17, 2020 /PRNewswire/ -- GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium ...
Background: Treatment of osteoarthritis with oral NSAID therapy provides pain relief but carries a substantial risk of adverse effects. Topical NSAID therapy offers an alternative to oral treatment, ...